Extracorporeal Membrane Oxygenator (ECMO) is a surrogate lung or heart that can be used in patients who suffer from heart or lung failure. The first reported adult ECMO case was in the year 1972, and first neonate ECMO case in 1975. This technology was used in children with heart disease or lung failure for many years in the western countries.
It was accepted as a treatment modality for adult patients after the 2003 Swine Flu pandemic, and its use became more global with more Asia Pacific countries utilizing ECMO for severe viral lung failure. In India, the use of ECMO was limited to cardiac surgery patients, and it was largely unknown as a life-saving option to the general population.
During the COVID10 pandemic, as the lung failures were severe and ventilators were not able to achieve gas exchange, ECMO emerged as a sought-after treatment modality. However, as the technology was new to India, the number of providers with expertise as well as number of hospitals with the infrastructure and equipment were limited.
ECMO ADOPTION PREREQUISITES
ECMO is costly, resource intensive, and needs skilled manpower. ECMO needs a multidisciplinary team effort, advanced diagnostics, trained nursing, special equipment and specifically designed ICU cubicles.
This infrastructure is usually present in cardiac and transplant centers. Patients admitted under adult or pediatric critical care, for both—cardiac surgery and/or for medical management of shock or respiratory failure—may benefit from ECMO.
Bu hikaye Healthcare Radius dergisinin March 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Healthcare Radius dergisinin March 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.